Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
Australian Ovarian Cancer Study, Management Group, Project and Data Managers, Research Nurses and Assistants, Clinical and Scientific Collaborators, GAMuT Collaborators
Research output: Contribution to journal › Article › peer-review
31Scopus
citations
Fingerprint
Dive into the research topics of 'Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses'. Together they form a unique fingerprint.